BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat

Reuters

Feb 27, 2025

** Shares of medical device maker Tandem Diabetes Care TNDM.O down 24% at $25.50

** Company late on Wednesday forecast 2025 sales between $997 mln and $1.007 bln vs. analysts' average estimate of $1.004 billion, according to data compiled by LSEG

** Says "muted seasonality" and "shipping delays" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM

** The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts

** "What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year" -Brokerage Citi

** Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million

** TNDM has risen 16.4% in the last 12 months

(Reporting by Siddhi Mahatole)

((Siddhiprabhanjan.mahatole@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2514800177"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514800177\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514800177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514800177","market":"us","top_or_hot":-1,"title":"BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat</title></head><body><p>** Shares of medical device maker Tandem Diabetes Care <span>TNDM.O</span> down 24% at $25.50</p><p>** Company late on Wednesday <span>forecast </span>2025 sales <span>between $997 mln and $1.007 bln vs.</span> analysts' average estimate of $1.004 billion, according to data compiled by LSEG</p><p>** Says \"muted seasonality\" and \"shipping delays\" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM</p><p>** The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts</p><p>** \"What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year\" -Brokerage Citi   </p><p>** Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million</p><p>** TNDM has risen 16.4% in the last 12 months</p><p> (Reporting by Siddhi Mahatole)</p><p> ((Siddhiprabhanjan.mahatole@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-27 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat</title></head><body><p>** Shares of medical device maker Tandem Diabetes Care <span>TNDM.O</span> down 24% at $25.50</p><p>** Company late on Wednesday <span>forecast </span>2025 sales <span>between $997 mln and $1.007 bln vs.</span> analysts' average estimate of $1.004 billion, according to data compiled by LSEG</p><p>** Says \"muted seasonality\" and \"shipping delays\" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM</p><p>** The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts</p><p>** \"What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year\" -Brokerage Citi   </p><p>** Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million</p><p>** TNDM has risen 16.4% in the last 12 months</p><p> (Reporting by Siddhi Mahatole)</p><p> ((Siddhiprabhanjan.mahatole@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNDM","symbol_name":"Tandem Diabetes","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI11K:1","article_id":"2514800177","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514800177","pubTimestamp":1740664871,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat** Shares of medical device maker Tandem Diabetes Care TNDM.O down 24% at $25.50** Company late on Wednesday forecast 2025 sale","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TNDM":"Tandem Diabetes"},"translate_title":"BUZZ-医疗设备制造商Tandem因2025年销售预测基本持平而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":0.9},"content_text":"BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat** Shares of medical device maker Tandem Diabetes Care TNDM.O down 24% at $25.50** Company late on Wednesday forecast 2025 sales between $997 mln and $1.007 bln vs. analysts' average estimate of $1.004 billion, according to data compiled by LSEG** Says \"muted seasonality\" and \"shipping delays\" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM** The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts** \"What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year\" -Brokerage Citi   ** Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million** TNDM has risen 16.4% in the last 12 months (Reporting by Siddhi Mahatole) ((Siddhiprabhanjan.mahatole@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}